BiotechTube
Home/Cayuga Biotech/Andrea Ashford-Hicks
AA

Andrea Ashford-Hicks

Chief Executive Officer

Cayuga Biotech

Therapeutic Areas

Hemorrhage ControlCoagulation Disorders

Cayuga Biotech Pipeline

DrugIndicationPhase
CAY001Life-threatening Hemorrhage (e.g., trauma, surgery, anticoagulant-related)Pre-clinical

Leadership Team at Cayuga Biotech

DK
Damien Kudela, PhD
Founder, Chief Science Officer
SB
Samina Bari
Corporate and Business Affairs
HB
Herb Brinkman, PhD
Head of CMC
HC
Holli Cherevka
Head of Clinical Operations
GL
Genmin Lu, PhD
Head of Translational Medicine
View full Cayuga Biotech profile